Search results
Transient loss of Polycomb components induces an epigenetic cancer fate - Nature
Nature· 5 days agoA transient perturbation of transcriptional silencing mediated by Polycomb proteins is sufficient to induce an epigenetic cancer cell fate in Drosophila in the absence of driver mutations.
Arrowhead begins trial for kidney disease treatment By Investing.com
Investing.com· 4 days agoArrowhead Pharmaceuticals, Inc. (NASDAQ: NASDAQ:ARWR) has initiated a Phase 1/2a clinical trial of...
Could a Novel RNA-Based Vaccine Strategy Stop Endless Boosters?
Technology Networks· 7 days agoEach year, seasonal influenza vaccines are designed to protect against the four main types of flu...
Chugai Pharmaceutical Co., Ltd. (CHGCF) Q1 2024 Earnings Call Transcript
Seeking Alpha· 4 days agoChugai Pharmaceutical Co., Ltd. (OTCPK:CHGCF) Q1 2024 Earnings Conference Call April 24, 2024 5:00 AM ETCompany ParticipantsKae Miyata - Head of Corporate...
Bio-Path (NASDAQ:BPTH) Coverage Initiated by Analysts at StockNews.com
ETF DAILY NEWS· 5 days agoStock analysts at StockNews.com started coverage on shares of Bio-Path (NASDAQ:BPTH – Get Free Report) in a report released on Wednesday. The brokerage set a “sell” rating on the stock. Separately ...
Vaccine breakthrough means no more chasing strains
UC Newsroom· 3 days agoEvery year, researchers try to predict the four influenza strains that are most likely to be prevalent during the upcoming flu season. The same is true of COVID vaccines, which have been reformulated ...
This vaccine eliminates all viruses
Weston Forum· 6 days agoA universal vaccine against all RNA viruses – this sounds too good to be true. American researchers are now one step closer to vaccination. Every year, scientists put their heads together to ...
Boehringer signs $1.3B deal with RNA biotech Ochre Bio to team up against MASH
FierceBiotech· 6 days agoBoehringer Ingelheim is making yet another bet that RNA therapies hold the key to treating...
Intratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models...
Morningstar· 6 days ago-Injection in murine tumors shows the compound is well tolerated -Studies support ongoing clinical trial of PH-762 as a neoadjuvant therapy for treatment of cSCC, melanoma, or Merkel cell carcinoma MARLBOROUGH, Mass., April 22, 2024 (GLOBE NEWSWIRE
Cancer May Arise From Epigenetic Changes, Study in Fruit Flies Suggests
GenomeWeb News· 4 days agoCancer may stem from transient epigenetic changes, even in the absence of related genetic alterations, according to a new study in fruit flies published in Nature on Wednesday. "Cancer is generally ...
